Privia Health Group, Inc.
Privia Health Group, Inc. (PRVA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRVA · as of Jun 8, 2026
Key Statistics
Explore Privia Health Group, Inc. Data
prva stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 22 · Buy rate: 90.9%
The PRVA analyst consensus is Buy, based on ratings from 22 Wall Street analysts over the past 3 months. The average 12-month price target is $30.00, representing +40.12% upside from the current price of $21.41.
Competitors & Peers
prva competitorsPRVA
ARQT
ATEC
HTFL
ICUI
LIVNStock Performance
Full HistoryAbout Privia Health Group, Inc.
Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the prim…
what is privia health group, inc. · prva stock overview · privia health group, inc. company profile · who is privia health group, inc. ceo · prva NASDAQ · privia health group, inc. headquarters · privia health group, inc. business segments
About Stock Overview & Key Data
Privia Health Group, Inc. (PRVA) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on NASDAQ since Apr 28, 2021. As of the latest trading session, PRVA stock price is $21.41, with a market capitalization of $2.7B. The stock has returned -7.92% over the past 12 months and -9.74% year-to-date.
According to 22 Wall Street analysts, the consensus rating for Privia Health Group, Inc. stock is Buy, with an average 12-month price target of $30.00. In fiscal year 2025, Privia Health Group, Inc. reported revenue of $2.1B and net income of $22.9M. For detailed data — including Privia Health Group, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Privia Health Group, Inc. (PRVA) stock price is $21.41. The stock is traded on NASDAQ under the ticker symbol PRVA. The 52-week range is $18.77 – $26.51.